Kampmann Melissa S. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,713 shares of the medical equipment provider’s stock after selling 650 shares during the period. Intuitive Surgical comprises 2.3% of Kampmann Melissa S.’s investment portfolio, making the stock its 20th biggest position. Kampmann Melissa S.’s holdings in Intuitive Surgical were worth $2,982,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Howard Capital Management Group LLC grew its position in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. boosted its holdings in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after buying an additional 9,194 shares during the period. Quest Partners LLC bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $173,000. Pathstone Holdings LLC boosted its holdings in Intuitive Surgical by 2.6% in the 3rd quarter. Pathstone Holdings LLC now owns 48,928 shares of the medical equipment provider’s stock worth $24,037,000 after buying an additional 1,228 shares during the period. Finally, Banque Cantonale Vaudoise boosted its holdings in Intuitive Surgical by 6.1% in the 3rd quarter. Banque Cantonale Vaudoise now owns 8,332 shares of the medical equipment provider’s stock worth $4,094,000 after buying an additional 480 shares during the period. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, BTIG Research raised their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $611.86.
Insider Buying and Selling
In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last 90 days. 0.90% of the stock is owned by company insiders.
Intuitive Surgical Stock Up 1.7 %
Shares of NASDAQ:ISRG opened at $492.06 on Thursday. The stock has a market cap of $175.26 billion, a PE ratio of 76.76, a PEG ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average is $564.39 and its 200 day moving average is $531.62. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- P/E Ratio Calculation: How to Assess Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is diluted earnings per share (Diluted EPS)?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.